TSX-V
LG.V
0,06 CA$
-8,33%
LGC Capital to Expand Global Footprint in Medical Cannabis Market Through Investment in Jamaica's Global Canna Labs Limited
Publié le 26 janvier 2018
LGC Capital Ltd.Symbol: TSX-V: LG
LGC to subscribe for a $2.5 million secured debenture of Jamaican cannabis company Global Canna Labs Limited, convertible into an initial 30% interest, and to acquire a 5% royalty on net sales. The Jamaican Cannabis Licensing Authority granted Global Canna Labs conditional approval for a Cultivator's Licence (Tier 3) (over 5 acres) on December 20, 2017 . Global Canna Labs plans to start cultivation of its first commercial cannabis crop by Q2 2018. Construction of Global Canna Labs' first dispensary is expected to start in Q1 2018 in Montego Bay's Hip Strip. Plans are also in place for Global Canna Labs to open an on-site farm store and a dispensary in Kingston, Jamaica by the end of 2018. MONTREAL , Jan. 26, 2018 /CNW Telbec/ - LGC Capital Ltd. (LG.V ) ("LGC ") is pleased to announce that it has signed a Letter of Intent with rapidly-developing Jamaican cannabis company Global Canna Labs Limited ("Global Canna Labs ") for a strategic investment in the Jamaican cannabis market as part of LGC's ongoing international expansion.
View original content with multimedia: http://www.newswire.ca/en/releases/archive/January2018/26/c1672.html